Table 2.
Overall agreement between assays (>1%).
| Reference | Comparison | N of comparison | TP | FN | FP | TN | Sensitivity | Specificity | Agreement | κ ∗ |
|---|---|---|---|---|---|---|---|---|---|---|
| Dako22C3 | SP142∗ | 115 | 29 | 38 | 5 | 43 | 43.3% | 89.6% | 62.6% | 0.251 |
| Dako28-8 | 107 | 47 | 12 | 7 | 41 | 79.7% | 85.4% | 82.2% | 0.645 | |
| SP142∗ | Dako22C3 | 115 | 29 | 5 | 38 | 43 | 85.3% | 53.1% | 62.6% | 0.299 |
| Dako28-8 | 109 | 21 | 7 | 34 | 47 | 75.0% | 58.0% | 62.4% | 0.251 | |
| Dako28-8 | Dako22C3 | 107 | 47 | 7 | 12 | 41 | 87.0% | 77.4% | 82.2% | 0.645 |
| SP142∗ | 109 | 21 | 34 | 7 | 47 | 38.2% | 87.0% | 62.4% | 0.299 |
TP: true positive; TN: true negative; FP: false positive; FN: false negative; TC: tumor cells; IC: immune cells. SP142 was scored by TC/IC > 1%/1%. ∗Cohen's kappa coefficient (κ).